Tag: pharmaceuticals

  • FDA Blocks Obesity Drug Over Cardiac Concerns

    The U.S. Food and Drug Administration (FDA) has told Orexigen Therapeutics Inc. in San Diego, California and Takeda Pharmaceutical Company Limited in Osaka, Japan that the agency is withholding approval of the companies’ candidate obesity management drug Contrave pending results of another clinical trial to address risks of heart disease. The companies released excerpts from…

  • Cancer Drug Aids Regeneration of Spinal Cord Nerve Cells

    A team of German, Dutch, and American researchers have found the cancer drug Taxol has properties that can help treat spinal cord injuries. The scientists reported their findings online this week in Science Express on the journal Science Web site. Two key factors impeding the regeneration of nerve cells after a spinal cord injury are…

  • Endo Pharma, Orion Corp. to Advance Cancer Drugs

    Endo Pharmaceuticals in Chadds Ford, Pennsylvania and Orion Corporation in Espoo, Finland said today they have a collaboration agreement for drug research and development in oncology. The partnership aims to advance eight discovery-phase cancer drug candidates by combining their relevant R&D programs. The collaboration also gives each company exclusive licensing rights to the other’s development-ready…

  • Singapore Univ., U.S. Company Partner on Vaccines

    Inviragen Inc. in Fort Collins, Colorado and the Duke-National University of Singapore Graduate Medical School (Duke-NUS) announced a partnership to research the transmission and prevention of infectious diseases. Their first  project will involve research and development of vaccines against diseases such as dengue fever, hand, foot and mouth disease, and chikungunya. Dengue infection is a…

  • Pathology Lab, Institute Partner on Cancer Drug Services

    Flagship Biosciences, a pathology lab in Flagstaff, Arizona and TGen Drug Development (TD2), in Scottsdale, Arizona, have teamed up to provide drug discovery and development services to cancer researchers. Flagship Biosciences is a pharmaceutical services company that offers digital pathology to test diseased tissue samples for biotech, pharmaceutical, and medical device customers. TD2 is a…

  • Grant Awarded to Company for Kennedy’s Disease Research

    AndroScience Corp., a drug discovery and development company in San Diego, California, said it received a $3.8 million translational research grant to help develop a treatment for spinal and bulbar muscular atrophy, also called Kennedy’s Disease. The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health awarded the grant. The…

  • Orphan Drug Status Granted for Melanoma Vaccine

    BioSante Pharmaceuticals Inc. said today it received from the U.S. Food and Drug Administration orphan drug designation for its melanoma cancer vaccine to treat stage IIb to IV melanoma. BioSante Pharmaceuticals is a specialty pharmaceutical company in Lincolnshire, Illinois. Orphan drug designation, as granted by the Orphan Drug Act, is for a product to treat…

  • Stem Cells Shown to Help Treat Spinal Cord Injuries

    A study by researchers from Case Western Reserve University School of Medicine in Cleveland, Ohio and Athersys Inc., a drug discovery company also in Cleveland, found adult stem cells can help treat spinal cord injuries in rodents. The study tested Athersys’s MultiStem product made of adult (non-embryonic) stem cells obtained from bone marrow. The findings…

  • Theraclone, Pfizer to Partner on Antibody R&D

    Theraclone Sciences Inc., a drug discovery and development company in Seattle, Washington, said today it agreed to a multi-year research and development collaboration with the global pharmaceutical company Pfizer. The deal involves use of Theraclone’s I-STAR technology to discover monoclonal antibodies against up to four targets in the areas of infectious disease and cancer. The…

  • Pharma Company, Institute Seek Alzheimer’s Targets

    Sanford-Burnham Medical Research Institute in La Jolla, California and Ortho-McNeil-Janssen Pharmaceuticals Inc. (OMJPI) in Titusville, New Jersey said today they formed a partnership to discover compounds for Alzheimer’s disease and other psychiatric disorders. Under the agreement, joint Sanford-Burnham and OMJPI teams will identify and validate new targets for drug discovery, leading to compounds suitable for…